Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Pain Management Drugs & Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pain Management Drugs & Devices in various end use industries. The expanding demands from the Burn Pain, Cancer Pain, Dental/Facial Pain and Migraine Headache Pain, are propelling Pain Management Drugs & Devices market.
Pharmaceuticals, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Devices segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pain Management Drugs & Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pain Management Drugs & Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pain Management Drugs & Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pain Management Drugs & Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pain Management Drugs & Devices covered in this report include Abbvie Inc., Astrazeneca Depomed Inc., Djo Global Inc., Eli Lilly & Co., Endo International, Glaxosmithkline, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson and Medtronic Inc., etc.
The global Pain Management Drugs & Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Pain Management Drugs & Devices market, by region:
Global Pain Management Drugs & Devices market, Segment by Type:
Global Pain Management Drugs & Devices market, by Application
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Pain Management Drugs & Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Pain Management Drugs & Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Pain Management Drugs & Devices Market Overview
1.1 Pain Management Drugs & Devices Product Overview
1.2 Pain Management Drugs & Devices Market Segment by Type
1.2.1 Pharmaceuticals
1.2.2 Devices
1.3 Global Pain Management Drugs & Devices Market Size by Type
1.3.1 Global Pain Management Drugs & Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Pain Management Drugs & Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Pain Management Drugs & Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pain Management Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Pain Management Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Pain Management Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Pain Management Drugs & Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Pain Management Drugs & Devices Sales Breakdown by Type (2018-2023)
2 Global Pain Management Drugs & Devices Market Competition by Company
2.1 Global Top Players by Pain Management Drugs & Devices Sales (2018-2023)
2.2 Global Top Players by Pain Management Drugs & Devices Revenue (2018-2023)
2.3 Global Top Players by Pain Management Drugs & Devices Price (2018-2023)
2.4 Global Top Manufacturers Pain Management Drugs & Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pain Management Drugs & Devices Market Competitive Situation and Trends
2.5.1 Pain Management Drugs & Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Pain Management Drugs & Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pain Management Drugs & Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Pain Management Drugs & Devices Market
2.8 Key Manufacturers Pain Management Drugs & Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pain Management Drugs & Devices Status and Outlook by Region
3.1 Global Pain Management Drugs & Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Pain Management Drugs & Devices Historic Market Size by Region
3.2.1 Global Pain Management Drugs & Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Pain Management Drugs & Devices Sales in Value by Region (2018-2023)
3.2.3 Global Pain Management Drugs & Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Pain Management Drugs & Devices Forecasted Market Size by Region
3.3.1 Global Pain Management Drugs & Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Pain Management Drugs & Devices Sales in Value by Region (2024-2029)
3.3.3 Global Pain Management Drugs & Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Pain Management Drugs & Devices by Application
4.1 Pain Management Drugs & Devices Market Segment by Application
4.1.1 Burn Pain
4.1.2 Cancer Pain
4.1.3 Dental/Facial Pain
4.1.4 Migraine Headache Pain
4.1.5 Musculoskeletal Pain
4.1.6 Neuropathic Pain
4.1.7 Obstetrical Pain
4.2 Global Pain Management Drugs & Devices Market Size by Application
4.2.1 Global Pain Management Drugs & Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Pain Management Drugs & Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Pain Management Drugs & Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pain Management Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Pain Management Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Pain Management Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Pain Management Drugs & Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Pain Management Drugs & Devices Sales Breakdown by Application (2018-2023)
5 North America Pain Management Drugs & Devices by Country
5.1 North America Pain Management Drugs & Devices Historic Market Size by Country
5.1.1 North America Pain Management Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Pain Management Drugs & Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Pain Management Drugs & Devices Sales in Value by Country (2018-2023)
5.2 North America Pain Management Drugs & Devices Forecasted Market Size by Country
5.2.1 North America Pain Management Drugs & Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Pain Management Drugs & Devices Sales in Value by Country (2024-2029)
6 Europe Pain Management Drugs & Devices by Country
6.1 Europe Pain Management Drugs & Devices Historic Market Size by Country
6.1.1 Europe Pain Management Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Pain Management Drugs & Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Pain Management Drugs & Devices Sales in Value by Country (2018-2023)
6.2 Europe Pain Management Drugs & Devices Forecasted Market Size by Country
6.2.1 Europe Pain Management Drugs & Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Pain Management Drugs & Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Pain Management Drugs & Devices by Region
7.1 Asia-Pacific Pain Management Drugs & Devices Historic Market Size by Region
7.1.1 Asia-Pacific Pain Management Drugs & Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Pain Management Drugs & Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Pain Management Drugs & Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Pain Management Drugs & Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Pain Management Drugs & Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Pain Management Drugs & Devices Sales in Value by Region (2024-2029)
8 Latin America Pain Management Drugs & Devices by Country
8.1 Latin America Pain Management Drugs & Devices Historic Market Size by Country
8.1.1 Latin America Pain Management Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Pain Management Drugs & Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Pain Management Drugs & Devices Sales in Value by Country (2018-2023)
8.2 Latin America Pain Management Drugs & Devices Forecasted Market Size by Country
8.2.1 Latin America Pain Management Drugs & Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Pain Management Drugs & Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Pain Management Drugs & Devices by Country
9.1 Middle East and Africa Pain Management Drugs & Devices Historic Market Size by Country
9.1.1 Middle East and Africa Pain Management Drugs & Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Pain Management Drugs & Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Pain Management Drugs & Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Pain Management Drugs & Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Pain Management Drugs & Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Pain Management Drugs & Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbvie Inc.
10.1.1 Abbvie Inc. Company Information
10.1.2 Abbvie Inc. Introduction and Business Overview
10.1.3 Abbvie Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbvie Inc. Pain Management Drugs & Devices Products Offered
10.1.5 Abbvie Inc. Recent Development
10.2 Astrazeneca Depomed Inc.
10.2.1 Astrazeneca Depomed Inc. Company Information
10.2.2 Astrazeneca Depomed Inc. Introduction and Business Overview
10.2.3 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Astrazeneca Depomed Inc. Pain Management Drugs & Devices Products Offered
10.2.5 Astrazeneca Depomed Inc. Recent Development
10.3 Djo Global Inc.
10.3.1 Djo Global Inc. Company Information
10.3.2 Djo Global Inc. Introduction and Business Overview
10.3.3 Djo Global Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Djo Global Inc. Pain Management Drugs & Devices Products Offered
10.3.5 Djo Global Inc. Recent Development
10.4 Eli Lilly & Co.
10.4.1 Eli Lilly & Co. Company Information
10.4.2 Eli Lilly & Co. Introduction and Business Overview
10.4.3 Eli Lilly & Co. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly & Co. Pain Management Drugs & Devices Products Offered
10.4.5 Eli Lilly & Co. Recent Development
10.5 Endo International
10.5.1 Endo International Company Information
10.5.2 Endo International Introduction and Business Overview
10.5.3 Endo International Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Endo International Pain Management Drugs & Devices Products Offered
10.5.5 Endo International Recent Development
10.6 Glaxosmithkline
10.6.1 Glaxosmithkline Company Information
10.6.2 Glaxosmithkline Introduction and Business Overview
10.6.3 Glaxosmithkline Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Glaxosmithkline Pain Management Drugs & Devices Products Offered
10.6.5 Glaxosmithkline Recent Development
10.7 Hisamitsu Pharmaceutical Co. Inc.
10.7.1 Hisamitsu Pharmaceutical Co. Inc. Company Information
10.7.2 Hisamitsu Pharmaceutical Co. Inc. Introduction and Business Overview
10.7.3 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Hisamitsu Pharmaceutical Co. Inc. Pain Management Drugs & Devices Products Offered
10.7.5 Hisamitsu Pharmaceutical Co. Inc. Recent Development
10.8 Johnson & Johnson
10.8.1 Johnson & Johnson Company Information
10.8.2 Johnson & Johnson Introduction and Business Overview
10.8.3 Johnson & Johnson Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Johnson & Johnson Pain Management Drugs & Devices Products Offered
10.8.5 Johnson & Johnson Recent Development
10.9 Medtronic Inc.
10.9.1 Medtronic Inc. Company Information
10.9.2 Medtronic Inc. Introduction and Business Overview
10.9.3 Medtronic Inc. Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Medtronic Inc. Pain Management Drugs & Devices Products Offered
10.9.5 Medtronic Inc. Recent Development
10.10 Novartis International Ag
10.10.1 Novartis International Ag Company Information
10.10.2 Novartis International Ag Introduction and Business Overview
10.10.3 Novartis International Ag Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Novartis International Ag Pain Management Drugs & Devices Products Offered
10.10.5 Novartis International Ag Recent Development
10.11 Pfizer
10.11.1 Pfizer Company Information
10.11.2 Pfizer Introduction and Business Overview
10.11.3 Pfizer Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Pfizer Pain Management Drugs & Devices Products Offered
10.11.5 Pfizer Recent Development
10.12 Purdue Pharmaceuticals Lp
10.12.1 Purdue Pharmaceuticals Lp Company Information
10.12.2 Purdue Pharmaceuticals Lp Introduction and Business Overview
10.12.3 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Purdue Pharmaceuticals Lp Pain Management Drugs & Devices Products Offered
10.12.5 Purdue Pharmaceuticals Lp Recent Development
10.13 Abbott
10.13.1 Abbott Company Information
10.13.2 Abbott Introduction and Business Overview
10.13.3 Abbott Pain Management Drugs & Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Abbott Pain Management Drugs & Devices Products Offered
10.13.5 Abbott Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pain Management Drugs & Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pain Management Drugs & Devices Industrial Chain Analysis
11.4 Pain Management Drugs & Devices Market Dynamics
11.4.1 Pain Management Drugs & Devices Industry Trends
11.4.2 Pain Management Drugs & Devices Market Drivers
11.4.3 Pain Management Drugs & Devices Market Challenges
11.4.4 Pain Management Drugs & Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pain Management Drugs & Devices Distributors
12.3 Pain Management Drugs & Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research